Myometrial cysts are overwhelmingly benign. In the vast majority of reported cases, these fluid-filled pockets within the muscular wall of the uterus turn out to be harmless, most commonly linked to adenomyosis or degenerating fibroids. That said, the word “cyst” on an imaging report understandably raises alarm, and a small number of case reports do describe malignant lesions that presented as cystic masses in the myometrium. Understanding what kinds of cysts form in the uterine wall, how doctors tell them apart, and when closer evaluation is warranted can help put an incidental finding in perspective.
What Myometrial Cysts Actually Are
The myometrium is the thick muscular layer of the uterus, and cysts can form within it for several different reasons. The most common cause is adenomyosis, a condition in which tissue resembling the uterine lining grows into the muscle. When that displaced tissue bleeds in response to hormonal cycles, small pockets of fluid or old blood can accumulate, creating cysts. These cysts are lined by ectopic endometrium and tend to grow as cyclical bleeding increases the pressure inside them, which is why they often cause progressively worsening menstrual pain.1Clinical and Experimental Reproductive Medicine. Adenomyotic cyst mimicking a congenital Müllerian anomaly: Diagnosis and treatment with laparoscopy
Fibroids (leiomyomas) can also develop cystic areas when parts of the tumor outgrow their blood supply and undergo what radiologists call cystic degeneration. These are not true cysts in the traditional sense but rather areas of tissue breakdown within a solid mass that fill with fluid. On imaging, they can look remarkably similar to other cystic lesions, which sometimes leads to diagnostic confusion.2PubMed Central. Diagnostic Challenge: Distinguishing Uterine Fibroid with Cystic Degeneration vs. Ovarian Cystic Malignancy. A Case Report.
Less commonly, myometrial cysts can arise from remnants of embryonic ducts (Gartner duct cysts), from nabothian-type inclusions that become trapped during cervical or uterine healing, or from rare congenital anomalies. The point is that “myometrial cyst” is a description of what imaging shows, not a single diagnosis. The underlying cause matters far more than the cyst itself.
The Adenomyosis Connection
Because adenomyosis is the single most common reason cysts appear within the myometrium, it deserves special attention. Adenomyosis has been classified into diffuse forms, where the entire muscle wall is affected, and focal forms, which include well-defined masses and cystic lesions. A 2015 classification system further divided adenomyotic cysts into five subtypes based on their position in the uterine wall, ranging from submucous or intramural cysts to exophytic growths to so-called uterine-like masses.1Clinical and Experimental Reproductive Medicine. Adenomyotic cyst mimicking a congenital Müllerian anomaly: Diagnosis and treatment with laparoscopy
On ultrasound, myometrial cysts are a reliable marker of adenomyosis. A study comparing women with histologically confirmed adenomyosis to controls found cysts in about two-thirds of the adenomyosis group versus roughly a third of controls. The cysts tended to be small, with a median maximum size around 7 to 8 millimeters in both groups.3Archives of Obstetrics and Gynaecology. Evaluation of Adenomyosis by MUSA-Based Transvaginal Ultrasound in Women Undergoing Hysterectomy When combined with other ultrasound features like a heterogeneous myometrium and subendometrial microcysts, the specificity for diagnosing adenomyosis climbed above 86%.4PubMed. Accuracy of ultrasound signs on two-dimensional transvaginal ultrasound in prediction of adenomyosis: prospective multicenter study
So if your imaging report mentions small myometrial cysts alongside features like an enlarged or asymmetric uterus, adenomyosis is the leading explanation. These cysts are not cancerous, though they can certainly cause symptoms like heavy periods and significant pelvic pain.
How Rare Is Malignancy
This is the question that drives most of the anxiety. A case series examining myometrial cysts directly stated that “in the vast majority of published cases, myometrial cysts represent benign pathologies,” while acknowledging rare case reports of malignant cysts, including a clear cell adenocarcinoma arising in cystic adenomyosis.5PubMed Central. Myometrial cysts: A case series A separate case report documented endometrioid adenocarcinoma developing within a cystic adenomyoma, concluding that while the risk exists, it highlights the value of long-term imaging follow-up rather than immediate alarm.6PubMed. Rare case of endometrioid adenocarcinoma arising from cystic adenomyosis
The broader context helps calibrate the risk. In a large study of over 2,200 women with myometrial lesions (most of which were solid, not purely cystic), about 95% turned out to be benign, roughly 2.3% were mesenchymal uterine malignancies like leiomyosarcoma, and about 2.6% were other malignancies.7PubMed. A clinical ultrasound algorithm to identify uterine sarcoma and smooth muscle tumors of uncertain malignant potential in patients with myometrial lesions A separate cohort of 455 women with mesenchymal tumors found malignancy in about 3.5% and tumors of uncertain malignant potential in under 1%.8PubMed. Novel approach to MRI based risk stratification of uterine myometrial lesions These figures cover the full spectrum of myometrial masses, not just cystic ones, and include leiomyosarcomas that typically present as solid or mixed masses rather than simple cysts.
A review of the literature on adenomyosis and malignancy noted that the types of cancer that can develop in adenomyotic tissue include epithelial carcinomas, Müllerian-type borderline tumors, and sarcomas such as adenosarcoma and endometrial stromal sarcoma.9PubMed Central. Adenomyosis and Its Possible Malignancy: A Review of the Literature These are serious diagnoses, but they are extraordinarily uncommon. The evidence overall suggests that a simple myometrial cyst, especially one found alongside classic adenomyosis signs in a premenopausal woman, carries a negligible malignancy risk.
Red Flags That Prompt Closer Evaluation
Because imaging alone cannot always provide a definitive answer, doctors rely on a combination of features to decide which myometrial lesions deserve further workup. The study of over 2,200 women identified several independent risk factors for malignancy among myometrial lesions: older age, a tumor diameter greater than 8 centimeters, irregular margins, and high vascularity on Doppler ultrasound. Conversely, the presence of acoustic shadowing, a feature typical of ordinary fibroids, was protective.7PubMed. A clinical ultrasound algorithm to identify uterine sarcoma and smooth muscle tumors of uncertain malignant potential in patients with myometrial lesions
On MRI, a modified algorithm incorporating factors like irregular tumor margins, menopausal status, and diffusion-weighted signal characteristics achieved 98% accuracy in classifying myometrial tumors as benign or malignant, missing only 3 out of 455 cases.8PubMed. Novel approach to MRI based risk stratification of uterine myometrial lesions MRI is also useful for characterizing adenomyotic cysts specifically, with high-signal foci on certain imaging sequences being considered characteristic of adenomyosis.10PubMed Central. MRI for adenomyosis: a pictorial review
In practical terms, a small, well-defined cyst in a woman of reproductive age with symptoms of adenomyosis is unlikely to prompt aggressive intervention. A large, irregularly shaped lesion with high blood flow in a postmenopausal woman is a different story entirely. The features of the lesion and the clinical context matter more than the mere presence of a cyst.
The Diagnostic Challenge With Degenerating Fibroids
One reason myometrial cysts generate concern is that they can be hard to distinguish from other conditions on imaging. When a fibroid undergoes cystic degeneration, it can mimic everything from an ovarian mass to a malignant lesion. In one reported case, both ultrasound and MRI failed to differentiate a pedunculated fibroid with cystic degeneration from a potentially malignant ovarian mass; the correct diagnosis came only after surgery and histological examination, which showed no signs of malignancy.2PubMed Central. Diagnostic Challenge: Distinguishing Uterine Fibroid with Cystic Degeneration vs. Ovarian Cystic Malignancy. A Case Report.
Similarly, focal adenomyosis can be confused with fibroids. One case in a young woman without typical risk factors was initially suspected to be a degenerating fibroid, but pathology after surgery revealed adenomyosis with cystic endometriosis within the uterine wall.11PubMed Central. Focal adenomyosis (intramural endometriotic cyst) in a very young patient – differential diagnosis with uterine fibromatosis These cases underscore that a definitive diagnosis sometimes requires tissue examination, but they also show that the eventual diagnosis is nearly always benign.
Juvenile Cystic Adenomyosis in Adolescents
A distinct subtype worth knowing about is juvenile cystic adenomyoma, which affects adolescents and young women and is considered a congenital anomaly rather than the acquired form of adenomyosis seen in older patients. These lesions likely develop from the persistence of Müllerian tissue near the insertion of the round ligament and may result from developmental dysfunction during fetal life.1Clinical and Experimental Reproductive Medicine. Adenomyotic cyst mimicking a congenital Müllerian anomaly: Diagnosis and treatment with laparoscopy
These cysts typically present with severe, progressively worsening menstrual pain that does not respond well to standard painkillers or hormonal therapy.12PubMed Central. Juvenile cystic adenomyosis: A case report and review of the literature In reported cases, MRI often reveals a well-defined mass with a cystic cavity within the myometrium, typically a few centimeters in diameter, lined by endometrial tissue.13PubMed. Juvenile cystic adenomyoma in a 19-year-old woman: a case report with a proposal for new diagnostic criteria The diagnostic challenge here is that these cysts can be mistaken for Müllerian anomalies like a rudimentary uterine horn, which would call for a completely different management approach.14F&S Reports. Juvenile cystic adenomyoma, a rare diagnostic challenge: Case Reports and literature review
Despite the intensity of symptoms, juvenile cystic adenomyomas are benign. The concern here is not malignancy but rather delayed diagnosis and unnecessary suffering if the condition is confused with something else.
Treatment Approaches
Management of myometrial cysts depends entirely on symptoms and the underlying diagnosis. A small cyst found incidentally on ultrasound in a woman with no symptoms may not need any treatment at all. For symptomatic adenomyotic cysts, the options range from hormonal suppression to surgery.
Hormonal therapy aims to quiet the estrogen-driven cycle that causes the ectopic endometrial tissue to bleed and the cysts to grow. A study comparing different hormonal approaches found that GnRH agonists were the most effective at shrinking uterine volume in adenomyosis, with a response rate above 96%. Other hormonal options like low-dose estrogen-progestin pills and dienogest had lower response rates, around 47% and 55% respectively.15PubMed Central. Efficacy of Hormonal Therapies for Decreasing Uterine Volume in Patients with Adenomyosis Hormonal treatment does not eliminate the cysts permanently but can control symptoms and reduce their size while medication continues.
Surgical options for women who want to preserve their uterus include excision of the cystic lesion (adenomyomectomy) and newer minimally invasive techniques. A recent case report described transcervical radiofrequency ablation for a symptomatic cystic adenomyoma, with complete resolution of the cyst and significant symptom relief at six months of follow-up.16PubMed Central. Novel application of transcervical radiofrequency ablation for symptomatic cystic adenomyosis: Case report For women who have completed childbearing and have severe symptoms, hysterectomy remains the definitive treatment, though it is obviously a last resort.
Fertility and Pregnancy Considerations
Adenomyosis and its associated cysts can affect fertility, and surgery to remove adenomyotic tissue introduces its own set of trade-offs for women planning pregnancy. A retrospective analysis comparing pregnancy outcomes in women who had undergone adenomyomectomy versus those with untreated adenomyosis found a mixed picture. The surgical group had significantly lower rates of preterm premature rupture of membranes, preeclampsia, and growth-restricted infants. However, half of the women who had surgery developed placenta accreta spectrum, a serious complication in which the placenta grows too deeply into the uterine wall. Blood loss during cesarean delivery was also higher in the surgical group, and one woman experienced uterine rupture at 30 weeks.17AJOG Global Reports. Possible risks and benefits of adenomyomectomy on pregnancy outcomes: a retrospective analysis
The thickness of the remaining uterine wall after surgery appears to be a critical factor. A study of 23 women who became pregnant after uterine-sparing surgery for adenomyosis found that roughly 44% had early miscarriages. Two of those cases involved uterine rupture, and both occurred when the wall had been thinned to 7 millimeters or less. The authors suggested that an optimal residual wall thickness of 9 to 15 millimeters balances the ability to conceive against the risk of rupture.18PubMed. Association of uterine wall thickness with pregnancy outcome following uterine-sparing surgery for diffuse uterine adenomyosis
These findings highlight that while myometrial cysts from adenomyosis are not dangerous in the cancer sense, they can complicate reproductive planning. Any woman considering surgery for an adenomyotic cyst who also wants to become pregnant should have a detailed conversation with her surgeon about how much tissue will be removed and how the remaining wall will be monitored.
Molecular Markers and Emerging Research
Researchers are beginning to look at what is happening at the molecular level inside adenomyotic cysts, and the findings so far are interesting for what they suggest about both the biology and the cancer question. An immunohistochemical analysis of two giant cystic adenomyomas found that the glands lining the cysts showed a pattern of protein expression that differed from the normal uterine lining. The cyst glands were positive for HNF-1β and pAKT and positive for estrogen receptors, but showed loss of PTEN and ARID1A expression, with a wild-type (normal) p53 pattern. Normal endometrial glands, by contrast, retained ARID1A and showed mixed PTEN results.19PubMed Central. Two Giant Cystic Uterine Adenomyomas in a Premenopausal Woman: The Largest Case to Date With Immunohistochemical Findings
The loss of PTEN and ARID1A is noteworthy because both are tumor suppressor genes whose inactivation is seen in various gynecologic cancers, particularly endometrioid and clear cell carcinomas. Finding these changes in benign cystic adenomyomas does not mean the cysts are precancerous, but it does suggest a molecular environment that, in theory, could be more permissive of malignant transformation over long periods. This kind of data is still very preliminary and comes from individual case reports, not large studies. But it offers one plausible biological explanation for the exceedingly rare cases in which cancer does arise within adenomyotic cysts, and it may eventually help identify which patients warrant closer surveillance.
When Symptoms Deserve Urgent Attention
Most women with myometrial cysts experience either no symptoms at all or the predictable cycle of painful, heavy periods associated with adenomyosis. Severe dysmenorrhea is the hallmark complaint, especially in the juvenile cystic adenomyoma variant, where all patients in reported case series suffered from severe menstrual pain and pelvic pain.20Human Reproduction. New cases of accessory and cavitated uterine masses (ACUM): a significant cause of severe dysmenorrhea and recurrent pelvic pain in young women Pain that worsens progressively over months, does not respond to over-the-counter medication, and disrupts daily life warrants imaging and a gynecology referral, not because cancer is likely but because effective treatments exist and delayed diagnosis leads to unnecessary suffering.
Symptoms that should raise more immediate concern include sudden onset of pelvic pain unrelated to the menstrual cycle, unexplained postmenopausal bleeding, rapidly increasing abdominal girth, or a mass that grows noticeably between imaging studies. These features do not necessarily indicate malignancy, but they overlap with the red flags that prompt doctors to investigate further, including the features identified in the large screening studies: lesions bigger than 8 centimeters, irregular borders, and high blood flow on Doppler.7PubMed. A clinical ultrasound algorithm to identify uterine sarcoma and smooth muscle tumors of uncertain malignant potential in patients with myometrial lesions In a postmenopausal woman especially, any new or enlarging myometrial cyst deserves a thorough workup, since the hormonal environment that usually explains these cysts in younger women is no longer present.